States Are Toughening Up Privacy Laws for At-Home DNA Tests
By Emily Mullin,
Wired
| 10. 21. 2021
IF YOU’VE EVER spit into a plastic tube or swabbed your cheek and mailed your saliva away to learn about your ancestry or health risks, you might have assumed that the company analyzing your DNA is legally required to keep your genetic data private. But you’d be wrong.
The Health Insurance Portability and Accountability Act, known as HIPAA, protects individuals’ medical information when it's handled by doctors, hospitals, and health insurance companies. This applies to genetic tests ordered by your doctor but not to those you can buy online directly from companies like 23andMe and Ancestry because these kits aren’t considered medical tests. As a result, the companies have largely operated in a legal gray area. Firms write their own privacy policies that customers agree to when they purchase a kit, but the companies can change these policies at any time.
That’s a problem, since genetic data can reveal all sorts of sensitive information about you—your ethnicity, your family connections, and even your likelihood of developing Alzheimer’s disease or certain cancers. Law enforcement officers are increasingly using consumer...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...